Depletion of S100A4+ stromal cells results in abnormal nipple development and nursing failure

preprint OA: closed
View at publisher

Abstract

The nipple and mammary gland are essential for the survival of mammalian offspring, providing postnatal nourishment. Their development, like that of epidermal appendages, depends on instructive signals from mesenchymal cells. S100A4 (S100 calcium binding protein A4, also known as fibroblast-specific protein 1) is expressed by mesenchymal cells and has been associated with hair follicle regeneration. S100A4-expressing cells have been implicated in the development of eccrine glands, and studies using S100a4-Cre to manipulate gene function have suggested that S100A4-expressing cells may contribute to mammary branching morphogenesis. However, the identity and functional contribution of S100A4-positive (S100A4+) cells to nipple and mammary development remain unclear. Here, we used a cell-depletion mouse model, S100a4-Cre;DTA , to investigate their role during lactation. S100a4-Cre;DTA dams exhibited a severe nursing defect leading to complete litter loss within the first day postpartum. Immunofluorescence and oxytocin stimulation assays revealed no abnormalities in mammary morphology, milk production, or alveolar contractility, but defective nipple development was observed. Bulk RNA sequencing of nipple tissue indicated inflammatory signatures. Lineage tracing and immunofluorescence identified S100A4+ cells as fibroblasts and immune cells in the nipple, while only immune cells expressed S100A4 in the mammary gland. Our study uncovers a previously unrecognized role of S100A4+ cells in nipple development, highlighting their importance for successful lactation and offering new insights relevant to breastfeeding medicine.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00